Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 6, 2002, Pages 625-626

  Koren, Claude ^a,b   Yerushalmi, Rinat ^a,b   Katz, Alan ^a,b   Malik, Hana ^a,b   Sulkes, Aaron ^a,b   Fenig, Eyal ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cervical carcinoma; Chemoradiation therapy; Cisplatin; Hypersensitivity reaction

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PACLITAXEL;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; BRONCHOSPASM; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COUGHING; DRUG HYPERSENSITIVITY; DYSPNEA; ENDOMETRIUM CANCER; FEMALE; FEVER; GYNECOLOGIC CANCER; HUMAN; HYPOTENSION; PRURITUS; RASH; TREATMENT OUTCOME; VOMITING;

ADULT; ANTINEOPLASTIC AGENTS; CISPLATIN; DRUG HYPERSENSITIVITY; ENDOMETRIAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; RADIATION-SENSITIZING AGENTS; UTERINE CERVICAL NEOPLASMS;

EID: 0036898553     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200212000-00020     Document Type: Article

References (9)

1. Keys HM, Bundy BN, Stehman FB, et al. A comparison of weekly cisplatin during radiation therapy versus irradiation alone, each followed by adjuvant hysterectomy in bulky stage IB cervical carcinoma: A randomised trial of the Gynecologic: Oncologic Group. N Engl J Med 1999;340:1154-61.
2. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatinum versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative paraaortic lymph nodes. A Gynecologic Oncologic Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-48.
3. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy versus pelvic and paraaortic radiation for high risk cervical cancer - A randomized Radiation Therapy Oncology Group clinical trial. N Engl J Med 1998;340:1134-43.
4. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatinum based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.
5. Alberts DS, Kronal R, Baker LH, et al. Phase II randomized trial of cisplatinum chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix. A Southern Oncology Group study. J Clin Oncol 1987;5:1791-5.
6. Britten RA, Evans AJ, Allalunis-Turner MJ, et al. Effect of cisplatinum on the clinically relevant radiosensitivity of human cervical carcinoma cell lines. Int J Radiat Oncol Biol Phys 1996;34:367-74.
7. Cleare MJ, Hughes EG, Jacoby B, et al. Immediate (type I) allergic responses to platinum compounds. Clin Allergy 1976;6:183-95.
8. Khan A, Hill JM, Grater W, et al. Atopic hypersensitivity to cis-dichlorodiammineplatinum (II) and other platinum complexes. Cancer Res 1975;3:2766-70.
9. Tachibana Y, Sekine H, Fukui I, et al. Combination chemotherapy with bleomycin, vinca alkaloid and cisplatin (BVP) for advanced urothelial cancer. Hinyokika Kiyo 1984;30:1095-9.